This inventor holds 1 USPTO granted patent. Top assignee: Ntc S.r.l.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Efthymios Koutris and Ophthalmic Pharmaceutical Innovation.
Introduction
Efthymios Koutris is an inventor based in Pallini, Greece. His patent work includes an ophthalmic pharmaceutical composition designed to help reduce intraocular pressure in patients with ocular hypertension or open-angle glaucoma. He is associated with Ntc S.r.l.
Latest Patents
Koutris is named on one patent: Ophthalmic Pharmaceutical Composition Containing a Combination of Brinzolamide and Brimonidine and Method of Preparation Thereof. The invention describes a multidose aqueous eye-drop composition combining brinzolamide and brimonidine. It also includes a borate, a single polyol, and benzalkonium chloride as an antimicrobial agent. The patent presents the formulation and its preparation method as an alternative to previously known ophthalmic compositions.
Career Highlights
A key highlight of Koutris’s recorded inventive work is his contribution to a pharmaceutical formulation addressing elevated intraocular pressure. The patent reflects an effort to combine two active ingredients in a multidose aqueous composition.
Collaborations
Koutris is associated with Ntc S.r.l. in connection with his patent work.
Conclusion
Efthymios Koutris’s documented innovation focuses on an ophthalmic formulation combining brinzolamide and brimonidine, with a preparation method intended for use in managing ocular hypertension and open-angle glaucoma.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile